BiotechTube
Home/Pipeline/RG002-02

RG002-02

HPV-associated HSIL / Persistent Infection / Cancer

PreclinicalActive

Key Facts

Indication
HPV-associated HSIL / Persistent Infection / Cancer
Phase
Preclinical
Status
Active
Company
RinuaGene Biotechnology

About RinuaGene Biotechnology

A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.

View full company profile

Therapeutic Areas

OncologyInfectious DiseaseRare Disease

Other HPV-associated HSIL / Persistent Infection / Cancer Drugs

DrugCompanyPhase
RG002 (RG002-01)RinuaGene BiotechnologyPhase 1/IIa
RG002-04RinuaGene BiotechnologyPreclinical